Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
<h4>Background</h4>To the extent that outcomes are mediated through negative perceptions of generics (the nocebo effect), observational studies comparing brand-name and generic drugs are susceptible to bias favoring the brand-name drugs. We used authorized generic (AG) products, which ar...
Main Authors: | Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn, John G Connolly, Michael A Fischer, Aaron S Kesselheim, Joshua J Gagne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-03-01
|
Series: | PLoS Medicine |
Online Access: | https://doi.org/10.1371/journal.pmed.1002763 |
Similar Items
-
The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
by: Ameet Sarpatwari, et al.
Published: (2016-02-01) -
Paying physicians to prescribe generic drugs and follow-on biologics in the United States.
by: Ameet Sarpatwari, et al.
Published: (2015-03-01) -
Competition and price among brand-name drugs in the same class: A systematic review of the evidence.
by: Ameet Sarpatwari, et al.
Published: (2019-07-01) -
Generic named entity extraction
by: Jara-Valencia, José Luis
Published: (2005) -
Trade names that have become generic names in anaesthesia
by: A A Abraham
Published: (2012-01-01)